Remove 2002 Remove Clinical Trials Remove Terpenes
article thumbnail

Best strains and terpenes for creativity

The Cannigma

We also don’t know which, if any, terpenes have an effect on creativity. The best strains for creativity are Type II, with a balance of THC and CBD and a terpene profile that includes pinene, linalool, and beta-caryophyllene. Best terpenes for creativity. So if cannabis does improve creativity for some people, how?

Terpenes 130
article thumbnail

Best strains and terpenes for focus and flow state

The Cannigma

There is certainly some evidence that cannabis may be helpful with increasing focus, in the right dose with the right terpenes and cannabinoids. The best weed strains to help you focus have a balance of CBD and THC, are energizing and stress-relieving, and have a terpene profile that includes pinene, linalool, or beta-caryophyllene.

Terpenes 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine. A typical dose is 150-500 mcg.

History 123
article thumbnail

NO BRAINER: CBD AND THC FOR HEAD INJURIES

Green Relief

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2002, the Journal of Neuroscience reported that the impact of induced cerebral ischemia is much more severe in CB1 knockout mice than in “wild type” mice with cannabinoid receptors.

THC 64
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Fig 1: Sucralose (In Study).

article thumbnail

Green Relief - Untitled Article

Green Relief

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2002, the Journal of Neuroscience reported that the impact of induced cerebral ischemia is much more severe in CB1 knockout mice than in “wild type” mice with cannabinoid receptors.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Its use in China, Tibet, India, Nepal, Japan (McPartland and Hegman 2018 , Touw 1981 ), Ancient Greece and Rome (Butrica 2002 ), and Iran, Iraq, Turkey, Syria, and the Balkans (McPartland and Hegman 2018 ; Lozano 1997 ; Aldrich 1997 ) goes back thousands of years. Bonini et al.